Eur Rev Med Pharmacol Sci 2020; 24 (10): 5193-5194

DOI: 10.26355/eurrev_202005_21297

Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents

A. Izzi, V. Messina, L. Rinaldi, P. Maggi

Department of Infectious Disease and Emergency Infectious Diseases, D. Cotugno Hospital, Azienda Ospedaliera dei Colli, Naples, Italy. izziantonio@yahoo.it


Free PDF Download

To cite this article

A. Izzi, V. Messina, L. Rinaldi, P. Maggi
Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 10
Pages: 5193-5194
DOI: 10.26355/eurrev_202005_21297